Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
30
NMPA:30
Drug Approvals
Vortioxetine Hydrobromide Tablets
- Product Name
- 氢溴酸伏硫西汀片
- Approval Number
- 国药准字H20253191
- Approval Date
- Jan 14, 2025
NMPA
Vortioxetine Hydrobromide Tablets
- Product Name
- 氢溴酸伏硫西汀片
- Approval Number
- 国药准字H20253190
- Approval Date
- Jan 14, 2025
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244719
- Approval Date
- Aug 27, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244720
- Approval Date
- Aug 27, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found